Our findings provide a new mechanistic insight into the role of ABL for the BMP-SMAD pathway in cancer cells and expand the concept that BMPs and their target genes lie downstream of the tyrosine kinase ABL in multiple lineages. The gene discussed is ABL1; the disease is cancer.